Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00823043 · ClinicalTrials.gov registry record
A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs
A clinical trial, sponsored by Vistakon Pharmaceuticals.
- Completed
- Registry status
- 103
- Enrollment target
NCT00823043: Completed study, sponsored by Vistakon Pharmaceuticals.
NCT00823043 is a clinical trial that has completed, run by Vistakon Pharmaceuticals. The registered enrollment target is 103 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00823043 has completed, sponsored by Vistakon Pharmaceuticals.
- COMPLETED
- Registry status
- 103 participants
- Enrollment target
Study Summary
The objective of the study was to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate. This was an observational study. Subjects with open-angle glaucoma or ocular hypertension were asked to complete a survey regarding their normal treatment. No treatment was prescribed.
Primary Outcome
Subjects reported burning/stinging after they put the drops in their eyes using the following scale: 0=never, 1=rarely, 2=sometimes, 3=frequently, 4=always.
Interventions
- DRUG timolol hemihydrate
- DRUG timolol maleate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 103 participants |
| Start Date | 2009-01 |
| Est. Completion | 2009-07 |
What the finished NCT00823043 record still lists
NCT00823043 is an observational study that tracks outcomes without assigning an intervention. The registered 103 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 2 interventions - of which timolol hemihydrate is the first listed.
NCT00823043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00823043 about?
NCT00823043 is a clinical study titled "A Comfort Survey of Open-angle Glaucoma or Ocular Hypertension Patients Treated With 2 Drugs". The objective of the study was to evaluate whether timolol hemihydrate is more comfortable upon instillation than timolol maleate in sorbate. This was an observational study. Subjects with open-angle glaucoma or ocular hypertension were asked to complete a survey regarding their normal treatment. No...
What is the current status of trial NCT00823043?
This trial is currently completed. The enrollment target is 103 participants. The study started on 2009-01. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00823043?
The interventions under investigation include: timolol hemihydrate (DRUG), timolol maleate (DRUG).
Who is sponsoring clinical trial NCT00823043?
This trial is sponsored by Vistakon Pharmaceuticals, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04690348 · 103 participants · Phase 2
Intracavitary Carrier-embedded Cs131 Brachytherapy for Recurrent Brain Metastases: a Randomized Phase II Study
- NCT05282277 · 103 participants · Phase 4
Examining the Effects of Estradiol on Neural and Molecular Response to Reward
- NCT05566769 · 103 participants · NA
Performance and Safety of a Digital Tool for Unsupervised Self-assessment of NMOSD
- NCT05834478 · 103 participants · Phase 3
Non-invasive Vagal Nerve Stimulation in Opioid Use Disorders UH3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia